Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein

被引:114
作者
Giambartolomei, S
Covone, F
Levrero, M
Balsano, C
机构
[1] Univ Rome La Sapienza, Fdn Andrea Cesalpino, Gene Express Lab, Rome, Italy
[2] Univ Aquila, Dept Internal Med, I-67100 Laquila, Italy
[3] Univ Cagliari, Dept Internal Med, Cagliari, Italy
关键词
HCV; core; Raf; Erk1/2; EGF; HCC;
D O I
10.1038/sj.onc.1204372
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and hepatocellular carcinoma (HCC) worldwide. The HCV capside core is a multifunctional protein with regulatory functions that affects transcription and cell growth in vitro and in vivo. Here, we show that both HCV genotype 1a and 3 core proteins activate MEK1 and Erk1/2 MAP kinases and that the costitutive expression of the HCV core results in a high basal activity of Raf1 and MAP/kinase/ kinase, as determined by endogenous Raf1 in vitro kinase assay and immunodetection of hyperphosphorylated Erk1 and Erk2 even after a serum starvation. Moreover, the activation of both Erk1/2 and the downstream transcription factor Elk-l in response to the mitogenic stimulus EGF is significantly prolonged. The sustained response to EGF in cells expressing the HCV core occurs despite a normal induction of the MAP phosphatases MKP regulatory feedback and is likely due to the costitutive activation of Raf-l activity. The ability of HCV core proteins to directly activate the MAP kinase cascade and to prolong its activity in response to mitogenic stimuli may contribute to the neoplastic transformation of HCV infected liver cells.
引用
收藏
页码:2606 / 2610
页数:5
相关论文
共 34 条
[1]   Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1 [J].
Aoki, H ;
Hayashi, J ;
Moriyama, M ;
Arakawa, Y ;
Hino, O .
JOURNAL OF VIROLOGY, 2000, 74 (04) :1736-1741
[2]   Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets [J].
Barba, G ;
Harper, F ;
Harada, T ;
Kohara, M ;
Goulinet, S ;
Matsuura, Y ;
Eder, G ;
Schaff, Z ;
Chapman, MJ ;
Miyamura, T ;
Brechot, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1200-1205
[3]   Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation [J].
Brondello, JM ;
Pouysségur, J ;
McKenzie, FR .
SCIENCE, 1999, 286 (5449) :2514-2517
[4]   Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study [J].
Bruno, S ;
Silini, E ;
Crosignani, A ;
Borzio, F ;
Leandro, G ;
Bono, F ;
Asti, M ;
Rossi, S ;
Larghi, A ;
Cerino, A ;
Podda, M ;
Mondelli, MU .
HEPATOLOGY, 1997, 25 (03) :754-758
[5]   Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [J].
Cacciola, I ;
Pollicino, T ;
Squadrito, G ;
Cerenzia, G ;
Orlando, ME ;
Raimondo, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :22-26
[6]   Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma [J].
Colombo, M .
JOURNAL OF HEPATOLOGY, 1999, 31 :25-30
[7]   Molecular virology of the hepatitis C virus [J].
De Francesco, R .
JOURNAL OF HEPATOLOGY, 1999, 31 :47-53
[8]  
Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt
[9]  
347::AID-IJC4&gt
[10]  
3.0.CO